UNCY Hedge Fund Ownership (Q2 2026)

Unicycive Therapeutics Inc (UNCY)

78 + Investors. Track Smart Money conviction in UNCY. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — UNCY

Based on 78 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q

For 4 consecutive quarters, more hedge funds added UNCY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

78 hedge funds hold UNCY right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +333% more funds vs a year ago

fund count last 6Q

+60 new funds entered over the past year (+333% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 75% buying

60 buying20 selling

Last quarter: 60 funds were net buyers (35 opened a brand new position + 25 added to an existing one). Only 20 were sellers (13 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+16 vs last Q)

new funds entering per quarter

Funds opening a new UNCY position: 14 → 8 → 19 → 35. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 62% entered in last year

■ 14% conviction (2yr+) ■ 24% medium ■ 62% new

Only 11 funds (14%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +32%, value -6%

Value

-5%

+32%

Last quarter: funds added +32% more shares while total portfolio value only changed -6%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

3 → 14 → 8 → 19 → 35 new funds/Q

New funds entering each quarter: 14 → 8 → 19 → 35. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 64% of holders entered in last year

■ 23% veterans ■ 13% 1-2yr ■ 64% new

Of 87 current holders: 56 (64%) entered in the past year, only 20 (23%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds

27 of 78 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

6.5

out of 10

Moderate Exit Risk

Exit risk score 6.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	78	50	56.0%
13F Shares	14M	10M	32.07%
Total Value	$65M	$69M	-5.51%
New Positions	35	19	+16
Increased Positions	24	12	+12
Closed Positions	7	3	+4
Reduced Positions	10	10	-
Total Calls	6	3	100.0%
Total Puts	3	3	-
PUT/CALL Ratio	0.5	1.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

56.0%

13F Shares

14M

10M

32.07%

Total Value

$65M

$69M

-5.51%

New Positions

+16

Increased Positions

+12

Closed Positions

Reduced Positions

Total Calls

100.0%

Total Puts

PUT/CALL Ratio

0.5

1.0

Bullish

Institutional Holders (2026 Q2)

78 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in UNCY. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 UNCY holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Dauntless Investment Group, LLC	0.79%	214,000	$1.0M
2	Diadema Partners LP	0.47%	792,600	$3.7M
3	Octagon Capital Advisors LP	0.42%	1,000,000	$4.7M
4	Pavaki Capital Management LLC	0.37%	90,000	$519K
5	Scientech Research LLC	0.28%	74,490	$349K
6	Vivo Capital, LLC	0.24%	550,000	$2.6M
7	Nantahala Capital Management, LLC	0.22%	1,401,447	$6.6M
8	Diametric Capital, LP	0.19%	374,132	$1.8M
9	Diadema Partners LP	0.18%	303,676	$1.4M
10	Persistent Asset Partners Ltd	0.13%	90,165	$423K
11	Logos Global Management LP	0.10%	473,563	$2.2M
12	Seven Fleet Capital Management LP	0.09%	103,400	$521K
13	J. Goldman & Co LP	0.04%	327,345	$1.5M
14	Prelude Capital Management, LLC	0.01%	27,719	$130K
15	Caption Management, LLC	0.01%	420,000	$2.0M
16	Gables Capital Management INC.	0.01%	3,000	$14K
17	Cantor Fitzgerald, L. P.	0.00%	50,000	$234K
18	Caption Management, LLC	0.00%	110,000	$516K
19	Chicago Partners Investment Group LLC	0.00%	21,410	$117K
20	Marshall Wace, LLP	0.00%	547,862	$2.6M
21	Los Angeles Capital Management LLC	0.00%	95,019	$446K
22	XTX Topco Ltd	0.00%	10,600	$50K
23	Millennium Management LLC	0.00%	271,456	$1.3M
24	MetLife Investment Management, LLC	0.00%	15,548	$73K
25	Citigroup Inc	0.00%	182,654	$857K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Unicycive Therapeutics Inc (UNCY)

What does the Smart Money Trend signal show for UNCY?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added UNCY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for UNCY?

More buyers than sellers — 75% buying: Last quarter: 60 funds were net buyers (35 opened a brand new position + 25 added to an existing one). Only 20 were sellers (13 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for UNCY holders?

Strong quality — 34% AUM from major funds: 27 of 78 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held UNCY?

Mostly new holders — 62% entered in last year: Only 11 funds (14%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Unicycive Therapeutics Inc (UNCY)

Smart Money Signals — UNCY

Buying streak — 4 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +333% more funds vs a year ago

More buyers than sellers — 75% buying

More new buyers each quarter (+16 vs last Q)

Mostly new holders — 62% entered in last year

Buying through price weakness — shares +32%, value -6%

Acceleration phase — new buyers rushing in

Early stage — 64% of holders entered in last year

Strong quality — 34% AUM from major funds

Institutional Sentiment Summary — UNCY

Hedge Fund Ownership: UNCY

Market Analysis: UNCY

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: UNCY

Hedge Fund Positioning: UNCY

Statistics: UNCY

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Unicycive Therapeutics Inc (UNCY)

Welcome to 13Foresight!